Flonase News
- Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Norvir Capsule (Presseportal)
Mexico City (ots/PRNewswire) - - Pivotal Study of Norvir Tablet Bioavailability Will Form the Basis of Request for Priority Regulatory Review Abbott (NYSE: ABT) presented pivotal data at the XVII International AIDS Conference ... - Abbott's Kaletra(R) Tablet Dosed Once-Daily Or Twice-Daily Demonstrated Similar Clinical Results Across Race And ... (Medical News Today)
Initial treatment regimens containing once-daily or twice-daily dosing of Abbott's (NYSE: ABT) protease inhibitor Kaletra(R) (lopinavir/ritonavir) tablet provided similar results for controlling the virus (reducing the amount of HIV-1) and improving the immune system (in - Abbott Study Shows Investigational Heat-Stable Norvir® Tablet Provides Similar Drug Levels To Current Norvir Capsule (Medical News Today)
Abbott presented pivotal data at the XVII International AIDS Conference (AIDS 2008) in Mexico City showing that its investigational Norvir® (ritonavir) tablet and the current soft-gelatin capsule provide similar levels of drug in the blood. - Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Norvir Capsule (PR Newswire via Yahoo! Finance)
Abbott presented pivotal data at the XVII International AIDS Conference in Mexico City today showing that its investigational Norvir® tablet and the current soft-gelatin capsule provide similar levels of drug in the blood. - Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Norvir Capsule (Thaipr.net)
Çѹ·Õè 8 ÊÔ§ËÒ¤Á 2551 10:10 ¹. Pivotal Study of Norvir Tablet Bioavailability Will Form the Basis of Request for Priority Regulatory Review Abbott (NYSE: ABT) presented pivotal data at the XVII International AIDS Conference (AIDS 2008) in Mexico City today showing that its investigational Norvir(R) (ritonavir) tablet and the current soft-gelatin capsule provide similar levels of drug in the blood. - Ragweed misery: How to find relief (Louisville Courier-Journal)
Get ready for the big sneeze. The ragweed season has begun, and that means life won't be pretty until the first frost for some people who are sensitive to the all-too-common pollen producer. - Boosted Reyataz And Lopinavir/R Achieve Similar Results For Undetectable Viral Load In Treatment-Naive HIV-1 Infected ... (Medical News Today)
Bristol-Myers Squibb Company (NYSE: BMY) announced results from a pre-specified subanalysis of the CASTLE study, in which once-daily boosted REYATAZ® (atazanavir sulfate) (REYATAZ 300 mg taken with 100 mg of ritonavir, or REYATAZ/r) and twice-daily co-formulated lopinavir 400 mg and ritonavir 100 - Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and ... (Thaipr.net)
Çѹ·Õè 6 ÊÔ§ËÒ¤Á 2551 09:25 ¹. HIV-Infected Women and Non-Whites New to Antiretroviral Therapy Respond Similarly to Men and Whites Initial treatment regimens containing once-daily or twice-daily dosing of Abbott's (NYSE: ABT) protease inhibitor Kaletra(R) (lopinavir/ritonavir) tablet provided similar results for controlling the virus (reducing the amount of HIV-1) and improving the immune system ... - Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Norvir Capsule (FinanzNachrichten)
Mexico City (ots/PRNewswire) - - Pivotal Study of Norvir Tablet Bioavailability Will Form the Basis of Request for Priority Regulatory Review Abbott (NYSE: ... - Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and ... (FinanzNachrichten)
Mexico City (ots/PRNewswire) - - HIV-Infected Women and Non-Whites New to Antiretroviral Therapy Respond Similarly to Men and Whites Initial treatment ...